Angiogenesis as a therapeutic target in cancer

Por Kumaran, Gireesh, Clamp, Andrew R, Jayson, Gordon C
Publicado no Clin Med (Lond) (2008)

The combination of circulating Ang1 and Tie2 levels predict progression free survival advantage in Bevacizumab-treated ovarian cancer patients

Por Backen, Alison, Renehan, Andrew G., Clamp, Andrew R., Berzuini, Carlo, Zhou, Cong, Oza, Amit, Bannoo, Selina, Scherer, Stefan J., Banks, Rosamonde E., Dive, Caroline, Jayson, Gordon C.
Publicado em 2014

Quantifying anti-vascular effects of monoclonal antibodies to VEGF: insights from multi-modality cross species imaging in colorectal cancer

Por O’Connor, James P B, Carano, Richard A D, Clamp, Andrew R, Ross, Jed, Ho, Calvin C K, Jackson, Alan, Parker, Geoff J M, Rose, Chris J, Peale, Franklin V, Friesenhahn, Michel, Mitchell, Claire L, Watson, Yvonne, Roberts, Caleb, Hope, Lynn, Cheung, Sue, Reslan, Hani Bou, Go, Mary Ann T, Pacheco, Glenn J, Wu, Xiumin, Cao, Tim C, Ross, Sarajane, Buonaccorsi, Giovanni A, Davies, Karen, Hasan, Jurjees, Thornton, Paula, del Puerto, Olivia, Ferrara, Napoleone, van Bruggen, Nicholas, Jayson, Gordon C
Publicado no Clin Cancer Res (2009)